A structural approach to selection bias, Epidemiology, vol.15, pp.615-640, 2004. ,
A new approach to causal inference in mortality studies, Mathematical Modelling, vol.7, pp.1393-512, 1986. ,
Association, causation, and marginal structural models, Synthese, vol.121, issue.1, pp.151-79, 1999. ,
Estimation of the causal effects of time-varying exposures. Longitudinal Data analysis, pp.553-99, 2008. ,
Marginal structural models and causal inference in epidemiology, Epidemiology, vol.11, issue.5, pp.550-60, 2000. ,
Marginal structural models to estimate the joint causal effect of nonrandomized treatments, J Am Stat Asso, vol.96, pp.440-448, 2001. ,
Approaches to inverse-probability-of-treatmentweighted estimation with concurrent treatments, J Clin Epidemiol, vol.66, issue.8, pp.51-57, 2013. ,
Effects of physical activity and body composition on functional limitation in the elderly: application of the marginal structural model, Epidemiology, vol.15, issue.4, pp.479-93, 2004. ,
Estimating the effects of multiple time-varying exposures using joint marginal structural models: alcohol consumption, injection drug use, and HIV acquisition, Epidemiology, vol.23, issue.4, pp.574-82, 2012. ,
Effect of tuberculosis on the survival of women infected with human immunodeficiency virus, Am J Epidemiol, vol.165, issue.10, pp.1134-1176, 2007. ,
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models, Am J Epidemiol, vol.158, issue.7, pp.687-94, 2003. ,
Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology, Am J Epidemiol, vol.159, issue.10, pp.926-960, 2004. ,
Simulating from marginal structural models with time-dependent confounding, Stat Med, vol.31, issue.30, pp.4190-206, 2012. ,
On the application of statistical learning approaches to construct inverse probability weights in marginal structural cox models: hedging against weight-model misspecification, Commun Stat Simul Comput, vol.2016, pp.1-30 ,
Performance of the marginal structural models under various scenarios of incomplete marker's values: a simulation study, Biom J, vol.57, issue.2, pp.254-70, 2015. ,
A simulation study of finite-sample properties of marginal structural cox proportional hazards models, Stat Med, vol.31, pp.2098-109, 2012. ,
Accuracy of conventional and marginal structural cox model estimators: a simulation study, Int J Biostat, vol.6, issue.2, p.13, 2010. ,
Flexible marginal structural models for estimating the cumulative effect of a time-dependent treatment on the hazard: reassessing the cardiovascular risks of Didanosine treatment in the Swiss HIV cohort study, J Am Stat Asso, vol.109, issue.506, pp.455-64, 2014. ,
Relation between three classes of structural models for the effect of a time-varying exposure on survival, Lifetime Data Anal, vol.16, issue.1, pp.71-84, 2010. ,
Simulation from a known cox MSM using standard parametric models for the g-formula, Stat Med, vol.33, issue.6, pp.1001-1015, 2014. ,
Simulation from structural survival models under complex time-varying data structures, J Am stat asso, 2008. ,
On computing standard errors for marginal structural cox models, Lifetime Data Anal, vol.20, issue.1, pp.106-137, 2014. ,
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: a: D study, J Acquir Immune Defic Syndr, vol.68, issue.5, pp.568-77, 2015. ,
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study, Lancet Oncol, vol.10, issue.12, pp.1152-1161, 2009. ,
Cohort profile: French hospital database on HIV (FHDH-ANRS CO4), Int J Epidemiol, vol.43, issue.5, pp.1425-1461, 2014. ,
Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV, J Clin Oncol, vol.30, issue.35, pp.4360-4366, 2012. ,
Constructing inverse probability weights for marginal structural models, Am J Epidemiol, vol.168, issue.6, pp.656-64, 2008. ,
On the distinction between interaction and effect modification, Epidemiology, vol.20, issue.6, pp.863-71, 2009. ,
Pharmacokinetic-pharmacodynamic modelling: history and perspectives, J Pharmacokinet Pharmacodyn, vol.33, issue.3, pp.227-79, 2006. ,
Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural cox model context, Stat Med, vol.36, issue.13, pp.2032-2079, 2017. ,
Doubly robust estimation in missing data and causal inference models, Biometrics, vol.61, issue.4, pp.962-73, 2005. ,
Estimation of regression coefficients when some Regressors are not always observed, J Am Stat Assoc, vol.89, issue.427, pp.846-66, 1994. ,
Targeted maximum likelihood based causal inference: part 1, Int J Biostat, vol.6, issue.2, p.2, 2010. ,
Targeted maximum likelihood based causal inference: part 2, Int J Biostat, vol.6, issue.2, p.3, 2010. ,
Methods for dealing with time-dependent confounding, Stat Med, vol.32, issue.9, pp.1584-618, 2013. ,
A tutorial on propensity score estimation for multiple treatments using generalized boosted models, Stat Med, vol.32, pp.3388-414, 2013. ,
The performance of different propensity score methods for estimating marginal hazard ratios, Stat Med, vol.32, issue.16, pp.2837-2886, 2013. ,
Comparison of statistical approaches dealing with timedependent confounding in drug effectiveness studies, Stat Methods Med Res, 2016. ,
Studying noncollapsibility of the odds ratio with marginal structural and logistic regression models, Stat Methods Med Res, vol.25, issue.5, pp.1925-1962, 2016. ,
Exposure to antiretroviral therapy and risk of cancer in HIVinfected persons, AIDS, vol.26, issue.17, pp.2223-2254, 2012. ,